Michael Smolinski

678 total citations
18 papers, 504 citations indexed

About

Michael Smolinski is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Michael Smolinski has authored 18 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Michael Smolinski's work include Protein Structure and Dynamics (4 papers), Computational Drug Discovery Methods (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Michael Smolinski is often cited by papers focused on Protein Structure and Dynamics (4 papers), Computational Drug Discovery Methods (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Michael Smolinski collaborates with scholars based in United States, Germany and China. Michael Smolinski's co-authors include David Hangauer, G. Klebe, A. Heine, Bernhard Baum, Johnson Y. N. Lau, Yahao Bu, Marek Freindorf, Sameer Urgaonkar, Irwin H. Gelman and James L. Clements and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Journal of Molecular Biology.

In The Last Decade

Michael Smolinski

18 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Smolinski United States 10 318 156 122 91 59 18 504
Noriaki Tatsuta United States 12 426 1.3× 40 0.3× 125 1.0× 123 1.4× 55 0.9× 21 731
Andriy G. Golub Ukraine 17 401 1.3× 107 0.7× 72 0.6× 266 2.9× 37 0.6× 27 703
Fedor N. Novikov Russia 14 348 1.1× 175 1.1× 111 0.9× 157 1.7× 70 1.2× 43 803
René Hemmig Switzerland 10 454 1.4× 68 0.4× 171 1.4× 103 1.1× 43 0.7× 13 647
Ky-Youb Nam South Korea 11 205 0.6× 59 0.4× 49 0.4× 117 1.3× 18 0.3× 19 569
Alexander Gozman United States 8 612 1.9× 139 0.9× 120 1.0× 61 0.7× 54 0.9× 22 778
Oleg V. Stroganov Russia 12 316 1.0× 173 1.1× 83 0.7× 131 1.4× 73 1.2× 40 652
Wei-Ven Tee Singapore 15 533 1.7× 211 1.4× 100 0.8× 49 0.5× 55 0.9× 21 616
Stéphane De Cesco Canada 11 316 1.0× 150 1.0× 82 0.7× 200 2.2× 34 0.6× 12 487
Lucas Gutiérrez Argentina 15 515 1.6× 125 0.8× 80 0.7× 114 1.3× 29 0.5× 36 829

Countries citing papers authored by Michael Smolinski

Since Specialization
Citations

This map shows the geographic impact of Michael Smolinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Smolinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Smolinski more than expected).

Fields of papers citing papers by Michael Smolinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Smolinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Smolinski. The network helps show where Michael Smolinski may publish in the future.

Co-authorship network of co-authors of Michael Smolinski

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Smolinski. A scholar is included among the top collaborators of Michael Smolinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Smolinski. Michael Smolinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Kun, et al.. (2022). Association between snoring and insulin levels in the US population: a cross-sectional study. Sleep And Breathing. 27(3). 1185–1193. 1 indexed citations
2.
Guo, Yang, et al.. (2022). Caffeine is negatively associated with depression in patients aged 20 and older. Frontiers in Psychiatry. 13. 1037579–1037579. 8 indexed citations
3.
Bu, Yahao, et al.. (2021). 465 Tirbanibulin, a novel anti-proliferative and pro-apoptotic agent for the treatment of actinic keratosis. Journal of Investigative Dermatology. 141(5). S81–S81. 4 indexed citations
4.
Urgaonkar, Sameer, Kamil Nosol, Ahmed M. Said, et al.. (2021). Discovery and Characterization of Potent Dual P-Glycoprotein and CYP3A4 Inhibitors: Design, Synthesis, Cryo-EM Analysis, and Biological Evaluations. Journal of Medicinal Chemistry. 65(1). 191–216. 50 indexed citations
5.
Smolinski, Michael, et al.. (2021). Discovery of Encequidar, First-in-Class Intestine Specific P-glycoprotein Inhibitor. Journal of Medicinal Chemistry. 64(7). 3677–3693. 35 indexed citations
6.
Wu, Jianming, Betty Yuen Kwan Law, Vincent Kam Wai Wong, et al.. (2020). HM30181A, a potent P-glycoprotein inhibitor, potentiates the absorption and <i>in vivo</i> antitumor efficacy of paclitaxel in an orthotopic brain tumor model. Cancer Biology and Medicine. 17(4). 986–1001. 10 indexed citations
7.
Lau, Johnson Yiu‐Nam, et al.. (2019). Eribulin ORA: A novel oral formulation of eribulin based on combination with the P-gp inhibitor HM30181A.. Journal of Clinical Oncology. 37(15_suppl). e12577–e12577. 1 indexed citations
8.
Smolinski, Michael, Yahao Bu, James L. Clements, et al.. (2018). Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361). Journal of Medicinal Chemistry. 61(11). 4704–4719. 72 indexed citations
9.
Ciesielski, Michael J., Yahao Bu, Stephan A. Munich, et al.. (2018). KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma. Journal of Neuro-Oncology. 140(3). 519–527. 12 indexed citations
10.
Baum, Bernhard, et al.. (2010). Non-additivity of Functional Group Contributions in Protein–Ligand Binding: A Comprehensive Study by Crystallography and Isothermal Titration Calorimetry. Journal of Molecular Biology. 397(4). 1042–1054. 127 indexed citations
11.
Sessions, E. Hampton, Michael Smolinski, Bo Wang, et al.. (2010). The development of benzimidazoles as selective rho kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(6). 1939–1943. 20 indexed citations
12.
Baum, Bernhard, Michael Smolinski, Marek Freindorf, et al.. (2010). Enhancement of Hydrophobic Interactions and Hydrogen Bond Strength by Cooperativity: Synthesis, Modeling, and Molecular Dynamics Simulations of a Congeneric Series of Thrombin Inhibitors. Journal of Medicinal Chemistry. 53(5). 2126–2135. 76 indexed citations
13.
Bu, Yahao, Michael Smolinski, Jun Qu, et al.. (2010). Abstract 2487: Mechanism of action KX01 (KX2-391), a novel tubulin polymerization and Src signaling inhibitor proceeding to Phase II clinical trials. Cancer Research. 70(8_Supplement). 2487–2487. 3 indexed citations
14.
Baum, Bernhard, et al.. (2009). Think Twice: Understanding the High Potency of Bis(phenyl)methane Inhibitors of Thrombin. Journal of Molecular Biology. 391(3). 552–564. 44 indexed citations
15.
Hangauer, David, et al.. (2007). Potent and selective in vitro and in vivo inhibition of tumor proliferation by KXO1, a novel non-ATP competitive Src inhibitor. Cancer Research. 67. 3245–3245. 7 indexed citations
16.
Gerlach, Christof, Michael Smolinski, H. Steuber, et al.. (2007). Thermodynamic Inhibition Profile of a Cyclopentyl and a Cyclohexyl Derivative towards Thrombin: The Same but for Different Reasons. Angewandte Chemie International Edition. 46(44). 8511–8514. 28 indexed citations
17.
Gerlach, Christof, Michael Smolinski, H. Steuber, et al.. (2007). Thermodynamisches Inhibitionsprofil eines Cyclopentyl‐ und eines Cyclohexylderivats gegenüber Thrombin: gleich, jedoch aus unterschiedlichem Grund. Angewandte Chemie. 119(44). 8664–8667. 3 indexed citations
18.
Corbin, Brian, et al.. (2004). Overview of the development of the pathfinder ultra-long duration balloon system. Advances in Space Research. 33(10). 1627–1632. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriaki Tatsuta Breakdown of academic impact, for papers by Andriy G. Golub Breakdown of academic impact, for papers by Fedor N. Novikov Breakdown of academic impact, for papers by René Hemmig Breakdown of academic impact, for papers by Ky-Youb Nam Breakdown of academic impact, for papers by Alexander Gozman Breakdown of academic impact, for papers by Oleg V. Stroganov Breakdown of academic impact, for papers by Wei-Ven Tee Breakdown of academic impact, for papers by Stéphane De Cesco Breakdown of academic impact, for papers by Lucas Gutiérrez
Rankless by CCL
2026